about
Heparin modulates the conformation and signaling of platelet integrin αIIbβ3Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial.Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway.Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling.Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and plateletsAngiographic and clinical outcomes of bivalirudin versus heparin in patients with acute coronary syndrome undergoing percutaneous coronary interventionPlatelets are dominant contributors to hypercoagulability after injuryHeparin: an intervenor in cell communication.Production of heparin-containing hydrogels for modulating cell responses.Clinical applications of bivalirudin in the cardiac catheterization laboratory.Antithrombotic therapy for ventricular assist devices in children: do we really know what to do?Aspirin and heparin in pregnancy.Platelet-targeted pharmacologic treatments as anti-cancer therapy.A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4.Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions.Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin.Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.Modular GAG-matrices to promote mammary epithelial morphogenesis in vitro.Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: randomised comparison of bivalirudin versus unfractionated heparin in patients at high risk of bleeding undergoing elective coronary stenting throught the femoral approach. ratio
P2860
Q30513893-475FDA09-EE8D-4246-B8DA-BB8DA0035D14Q33400450-040AB09D-CBB9-4861-ADC2-40A1DB148186Q34074360-205E1FFA-3272-48D6-8F2B-5AC44323DE76Q35001659-5D02F610-51CF-4E06-8531-0D780E4A8BB5Q35995399-3DFC312D-DA7D-4BBC-B1F3-DC2DDB390BF1Q36940793-0913DF65-D8EF-46EE-A4A3-A868AA059E46Q37078508-4BACC73A-CC73-4DFF-AE6D-A5CF5A00AD6FQ37334941-51562FF2-044F-4ED5-B2C5-2DD0F2342133Q37352245-D39CE671-1668-4789-8710-0C49BC6471EFQ37811622-2C27DB48-977A-4855-9DB3-DFD7937B1E81Q38543315-F943CDB8-8ABF-469C-97D5-F63A7B44D40DQ38544097-C3E2779D-FAD7-4928-B326-6F6BF7F56BF2Q38657846-49FF01F5-9F03-491C-A3BA-5F9ED78C191DQ40075063-A4924512-22E9-4234-949F-2F29D3648E82Q40558058-66B4F646-CAB2-41EF-BB25-E92F306D903DQ42829962-C111C2AA-44A8-4E29-B21D-9905AFCDF492Q46970324-82AD1170-92A9-4E79-BA56-89A8E4FA4B01Q47255365-22EC0B03-3092-49F2-AD76-B9E24A523169Q50085838-3F9036DF-EE3C-4265-88F1-76A0E5D5391DQ53563183-26AB8DC8-C920-48D1-B37F-62C9C5EE2187
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Heparin modulates integrin function in human platelets.
@ast
Heparin modulates integrin function in human platelets.
@en
type
label
Heparin modulates integrin function in human platelets.
@ast
Heparin modulates integrin function in human platelets.
@en
prefLabel
Heparin modulates integrin function in human platelets.
@ast
Heparin modulates integrin function in human platelets.
@en
P2093
P356
P1476
Heparin modulates integrin function in human platelets.
@en
P2093
Blystone SD
Kusumoto S
P304
P356
10.1067/MVA.2001.112696
P577
2001-03-01T00:00:00Z